The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway
暂无分享,去创建一个
W. Jiang | P. Colombo | J. Eliaou | A. Sanders | N. Bonnefoy | J. Bastid | G. Alberici | A. Bensussan | J. Giustiniani | M. Lapierre | Cécile Déjou | K. Frewer | H. Michaud | Stéphanie Cochaud | E. Laprévotte | S. Du Manoir | Marion Philippe | W. Jiang | Marion Lapierre